CoChat

Current Strategies for Increasing Knock-In Efficiency in CRISPR/Cas9-Based Approaches

Open access
Leal, Andrés, Herreno-Pachón, Angelica, Benincore-Flórez, Eliana, Karunathilaka, Amali, Tomatsu, Shunji · 2024 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.

Abstract

Since its discovery in 2012, the clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) system has supposed a promising panorama for developing novel and highly precise genome editing-based gene therapy (GT) alternatives, leading to overcoming the challenges associated with classical GT. Classical GT aims to deliver transgenes to the cells via their random integration in the genome or episomal persistence into the nucleus through lentivirus (LV) or adeno-associated virus (AAV), respectively. Although high transgene expression efficiency is achieved by using either LV or AAV, their nature can result in severe side effects in humans. For instance, an LV (NCT03852498)- and AAV9 (NCT05514249)-based GT clinical trials for treating X-linked adrenoleukodystrophy and Duchenne Muscular Dystrophy showed the development of myelodysplastic syndrome and patient’s death, respectively. In contrast with classical GT, the CRISPR/Cas9-based genome editing requires the homologous direct repair (HDR) machinery of the cells for inserting the transgene in specific regions of the genome. This sophisticated and well-regulated process is limited in the cell cycle of mammalian cells, and in turn, the nonhomologous end-joining (NHEJ) predominates. Consequently, seeking approaches to increase HDR efficiency over NHEJ is crucial. This manuscript comprehensively reviews the current alternatives for improving the HDR for CRISPR/Cas9-based GTs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms25052456

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Cas9 protein structure and Cas9-mediated DNA double-strand breaks. In (a), the full Cas9 protein structure isolated from Streptococcus pyogenes is shown. Notice the recognizing (REC) and nuclease (NUC) lobes, which mediate the targeted DNA recognition and double-strand break, respectively. The arginine (Arg) 1333 and 1335 residues responsible for PAM sequence recognition are also displayed. In (b), a classical overview of the ribonucleoprotein (RNP) complex (Cas9 together with sgRNA) interacting with the targeted DNA is shown. The histidine 840 (H840) catalyzes the break of the sgRNA interacting DNA strand, while aspartate 10 (D10) mediates breaking on the opposite strand. Note that the RuvC endonuclease domain comprises three segments: RuvC I, II, and III, while the HNH catalytic domain comprises only one segment. Likewise, three alpha-helical domains (HD) at the REC lobe are placed and primarily responsible for nucleic acid binding. Finally, L-I and L-II are key linkers that aid the connection between RuvC and HNH. CTD: Carboxy-terminal domain. This figure was created with BioRender.com.
Figure 1 Cas9 protein structure and Cas9-mediated DNA double-strand breaks. In (a), the full Cas9 protein structure isolated from Streptococcus pyogenes is shown. Notice the recognizing (REC) and nuclease (NUC) lobes, which mediate the targeted DNA recognition and double-strand break, respectively. The arginine (Arg) 1333 and 1335 residues responsible for PAM sequence recognition are also displayed. In (b), a classical overview of the ribonucleoprotein (RNP) complex (Cas9 together with sgRNA) interacting with the targeted DNA is shown. The histidine 840 (H840) catalyzes the break of the sgRNA interacting DNA strand, while aspartate 10 (D10) mediates breaking on the opposite strand. Note that the RuvC endonuclease domain comprises three segments: RuvC I, II, and III, while the HNH catalytic domain comprises only one segment. Likewise, three alpha-helical domains (HD) at the REC lobe are placed and primarily responsible for nucleic acid binding. Finally, L-I and L-II are key linkers that aid the connection between RuvC and HNH. CTD: Carboxy-terminal domain. This figure was created with BioRender.com.CC BY · PubMed Central
Figure 2 Major steps in non-homologous end joining (NHEJ) and Homology-directed repair (HDR). NHEJ is initiated by binding of Ku to the DSB ends. This is followed by recruiting DNA-PKcs and other necessary scaffolding factors that bring DSB ends together. Nucleases process the incompatible ends, polymerases fill gaps, and finally, the ends are ligated by DNA ligases. This process ultimately leads to the formation of INDELs. HDR is initiated by the binding of MRN that stabilizes DSB ends. Then, 5′ exonucleases produce short-range resections followed by long-range resections. The long 3′ overhangs are directed for homology search and strand invasion by RAD51, leading to D-loops’ formation. Finally, the exchanged DNA strands are resolved, leading to precise editing. Several platforms can be used as donor templates, including long single-stranded oligodeoxynucleotide (lssDNA), single-stranded oligodeoxynucleotide (ssODN), double-stranded oligodeoxynucleotide (dsODN), and double-stranded DNA (dsDNA) which can be carried through non-viral vectors, as well as DNA templates loaded into viral vectors. For more details related to donor templates and their impact on HDR, we strongly encourage readers to review the paper by Shakirova et al., 2023 [52]. Although differences in the recognition of ssDNA (i.e., BRCA1) and dsDNA (i.e., BRCA2) have been well-documented, in both scenarios, the homologous recombination takes place, leading to precise genome editing in the context of the CRISPR/Cas9 system. This figure was created with BioRender.com.
Figure 2 Major steps in non-homologous end joining (NHEJ) and Homology-directed repair (HDR). NHEJ is initiated by binding of Ku to the DSB ends. This is followed by recruiting DNA-PKcs and other necessary scaffolding factors that bring DSB ends together. Nucleases process the incompatible ends, polymerases fill gaps, and finally, the ends are ligated by DNA ligases. This process ultimately leads to the formation of INDELs. HDR is initiated by the binding of MRN that stabilizes DSB ends. Then, 5′ exonucleases produce short-range resections followed by long-range resections. The long 3′ overhangs are directed for homology search and strand invasion by RAD51, leading to D-loops’ formation. Finally, the exchanged DNA strands are resolved, leading to precise editing. Several platforms can be used as donor templates, including long single-stranded oligodeoxynucleotide (lssDNA), single-stranded oligodeoxynucleotide (ssODN), double-stranded oligodeoxynucleotide (dsODN), and double-stranded DNA (dsDNA) which can be carried through non-viral vectors, as well as DNA templates loaded into viral vectors. For more details related to donor templates and their impact on HDR, we strongly encourage readers to review the paper by Shakirova et al., 2023 [52]. Although differences in the recognition of ssDNA (i.e., BRCA1) and dsDNA (i.e., BRCA2) have been well-documented, in both scenarios, the homologous recombination takes place, leading to precise genome editing in the context of the CRISPR/Cas9 system. This figure was created with BioRender.com.CC BY · PubMed Central
Figure 3 Strategies for increasing the knock-in efficiency in CRISPR/Cas9-based genome editing. Increasing CRISPR/Cas9-mediated genome editing events involves factors such as the type of cell (a), as well as indirect (b) or direct (c) HDR modulation by using several strategies. Several small molecules can also achieve HDR increase, although their full mechanism of action is still to be uncovered (d). This figure was created with BioRender.com.
Figure 3 Strategies for increasing the knock-in efficiency in CRISPR/Cas9-based genome editing. Increasing CRISPR/Cas9-mediated genome editing events involves factors such as the type of cell (a), as well as indirect (b) or direct (c) HDR modulation by using several strategies. Several small molecules can also achieve HDR increase, although their full mechanism of action is still to be uncovered (d). This figure was created with BioRender.com.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 130 references

Cited by

See all 65

Metadata

Authors
Leal, A., Herreno-Pachón, A., Benincore-Flórez, E., Karunathilaka, A., & Tomatsu, S.
Affiliations
  • Pontificia Universidad Javeriana (CO)
  • Nemours Children’s Health, Wilmington, DE 19803, USA
  • Nemours Children's Health System (US)
  • Thomas Jefferson University (US)
Corresponding author
Tomatsu, Shunji
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2024-02-20
Volume
25
Issue
5
Pages
2456
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4391968889
Cited by
58
References
130
Citations by year
2026: 23 · 2025: 29 · 2024: 6
FWCI
2.36
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • The Medicine Forum (submittedVersion, cc-by)
Funders
  • A Cure for Robert, Inc. (1R01HD102545-01A1)
  • Austrian MPS society (1R01HD102545-01A1)
  • The Carol Ann Foundation (1R01HD102545-01A1)
  • Angelo R. Cali and Mary V. Cali Family Foundation, Inc. (1R01HD102545-01A1)
  • The Vain and Harry Fish Foundation, Inc. (1R01HD102545-01A1)
  • The Bennett Foundation (1R01HD102545-01A1)
  • Jacob Randall Foundation (1R01HD102545-01A1)
  • Nemours Funds (1R01HD102545-01A1)
  • Eunice Kennedy Shriver (1R01HD102545-01A1)
  • National Institute of Child Health and Human Development of the National Institutes of Health (NICHD) (1R01HD102545-01A1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Keywords
CRISPR/Cas9, knock-in efficiency, homologous recombination, non-homologous end joining, genome editing, gene therapy, lentivirus, adeno-associated virus, X-linked adrenoleukodystrophy, Duchenne muscular dystrophy, myelodysplastic syndrome
MeSH terms
Gene Editing, Animals, Humans, Mammals, Genetic Therapy, DNA End-Joining Repair, Recombinational DNA Repair, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current Strategies for Increasing Knock-In Efficiency in CRISPR/Cas9-Based Approaches. https://app.cochat.ai/papers/10.3390/ijms25052456
The paper
Leal, A., Herreno-Pachón, A., Benincore-Flórez, E., Karunathilaka, A., & Tomatsu, S. (2024). Current Strategies for Increasing Knock-In Efficiency in CRISPR/Cas9-Based Approaches. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052456

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.